March 29, 2023- March 30, 2023/ 9:00 am - 2:00 pm
Day 2 & 3: Virtual
Innovation Week Agenda: Agenda SI23 ENGLISH
Andrew Jenner, Interpat DG, will be contributing to the discussion on Innovation Ecosystems (Panel 8) on 30 March.
Register in the link below
Panel 4: Overcoming challenges in cancer care: an interdisciplinary approach
Panel 5: Innovations in care and delivery of treatments: expanding access
Panel 6: Technology as a key factor to reduce health inequities
Panel 7: Facing the challenges of mental health and dementia: a multidisciplinary perspective
Panel 8: Innovation ecosystems: factor for social development in health
Panel 9: Advanced therapies: changing the course in disease care
Panel 10: Maximizing the impact on health with a value-based approach
Panel 11: Clinical research: trends in the innovation industry
March 28, 2023- March 28, 2023/ 9:00 am - 1:45 pm
Day 1: On-site live event
To commemorate their anniversary, AMIIF will be holding the traditional innovation week. This year it is organised in conjunction with the Latin American Federation of the Pharmaceutical Industry (FIFARMA). There will be participation from several international speakers from WIPO, IFPMA and other organisations.
Andrew Jenner, DG of INTERPAT will participate in the discussions on the Innovation Ecosystems (Day 3, Panel 8)
Innovation Week Agenda: Agenda SI23 ENGLISH
Day 1
Panel 1: Ethics and social value in the pharma industry and the health sector
Panel 2: Experiences in care for noncommunicable diseases with a gender approach
Panel 3: Advances and Challenges of patient associations
November 13, 2023- November 15, 2023/ -
Our Winter 2023 General Assembly meeting will be held in Copenhagen, Denmark from Monday 13 November-Wednesday 15 November 2023. (Interpat members and affiliates only)
June 12, 2023- June 14, 2023/ -
Our Summer 2023 General Assembly will be held in Seoul, South Korea from Monday 12 June-Wednesday 14 June 2023. (Interpat members and affiliates only)
April 26, 2021- April 26, 2021/ 11:00 am - 3:00 pm
Medical innovations driven by the biopharmaceutical industry have played a fundamental role in helping people live longer, healthier lives. As the global population’s health needs become increasingly complex, it is ever more essential that we research and develop life-saving medicines and vaccines to meet these challenges. Intellectual Property (IP) has been central to great scientific advances and for ensuring that patients have access to this innovation. IP helps foster long term investment to benefit patients – today and tomorrow.
